The FreeStyle Libre system now has over 300,000 users in 35 countries and has secured reimbursement in 13, most recently in France. Abbott has been operating in Ireland since 1946 and serves the Irish market with a diverse range of health care products spanning diagnostics, medical devices and nutrition. Abbott employs almost 3,000 people across 10 sites in Ireland. Major elements of the FreeStyle Libre system manufacturing and assembly take place in County Cork.
Since its launch in 2016 we have said we are committed to pursuing reimbursement for the FreeStyle Libre system via the Health Service Executive because we believe it is the responsible thing to do. That’s why we invested heavily in several clinical trials to demonstrate to payers the value and results that patients and physicians are experiencing with the FreeStyle Libre system.
Abbott’s application was acknowledged by the Primary Care Reimbursement Service of the Health Service Executive on 6th February 2017. It will be considered in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. The application will be assessed for listing under reimbursable items for people (aged 4 and above) with diabetes who intensively use insulin; namely those requiring multiple daily injections of insulin (MDIs).
FreeStyle, Libre and related brand marks are trademarks of Abbott Diabetes Care Inc in various jurisdictions.
Prepared August 2017. ADCMDP170171